BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2230926
,
IL1A
,
Response to oxidative stress
,
Ischemia
,
Neuron
,
Pharmacogenetics
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
BTLA
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Lymph nodes
Spleen
Tonsil
Ileum mucosa
Bone marrow
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Infection due to Citrobacter
Whipple's disease
Rift valley fever
Disease caused by parasite
Vesicular stomatitis Indiana virus disease
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
thiazovivin
LMP2A protein, Human herpesvirus 4
Ouabain
JM 3100
Gonanes
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
KDM4B
G9a
Notch1
UBTF
UBTF
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
BTLA-derived peptides as inhibitors of BTLA/HVEM complex formation - design, synthesis and biologica…
T Cells Expressing CAR Equipped With Extracellular Domain of BTLA Are Effective Against HVEM-over-ex…
The role of the BTLA-HVEM complex in the pathogenesis of autoimmune diseases.
Targeting the HVEM protein using a fragment of glycoprotein D to inhibit formation of the BTLA/HVEM …
BTLA+CD200+ B cells dictate the divergent immune landscape and immunotherapeutic resistance in metas…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte At…
Safety, Tolerability and Pharmacokinetics of a Recombinant Humanized mAb Specific to B-and T-Lymphoc…
A Phase I Clinical Study of Recombinant Humanized Anti-BTLA Monoclonal Antibody (JS004) Injection Co…
A Phase I Clinical Study of JS004 in Subjects With Recurrent/Refractory Malignant Lymphoma of China
The Safety and Efficacy of Multiple-dose of JS004 in Subject With HNC
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ